Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: North America Direct-to-Consumer Laboratory Testing Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Key Insights
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Disease Prevalence & Incidence Rate
5.3. Regulatory Scenario
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type

7. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Cancer
7.3.2.2. STDs
7.3.2.3. Others
7.3.3. CBC
7.3.4. Diabetes testing
7.3.5. TSH testing
7.3.6. Others
7.4. Market Attractiveness Analysis, by Test Type

8. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Specialty Labs
8.3.4. Diagnostic Centers
8.4. Market Attractiveness Analysis, by End-user

9. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Country
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. U.S.
9.2.2. Canada
9.3. Market Attractiveness Analysis, by Country

10. Competition Landscape
10.1. Market Player - Competition Matrix (by tier and size of companies)
10.2. Market Share Analysis, by Company, 2020
10.3. Company Profiles
10.3.1. Quest Diagnostics Incorporated
10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.1.2. Product Portfolio
10.3.1.3. Strategic Overview
10.3.1.4. SWOT Analysis
10.3.2. Laboratory Corporation of America Holdings
10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.2.2. Product Portfolio
10.3.2.3. Strategic Overview
10.3.2.4. SWOT Analysis
10.3.3. 23andMe, Inc.
10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.3.2. Product Portfolio
10.3.3.3. Strategic Overview
10.3.3.4. SWOT Analysis
10.3.4. ANY LAB TEST NOW
10.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.4.2. Product Portfolio
10.3.4.3. Strategic Overview
10.3.4.4. SWOT Analysis
10.3.5. Direct Labs LLC
10.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.5.2. Product Portfolio
10.3.5.3. Strategic Overview
10.3.5.4. SWOT Analysis
10.3.6. Everlywell
10.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.6.2. Product Portfolio
10.3.6.3. Strategic Overview
10.3.6.4. SWOT Analysis
10.3.7. MyMedLab
10.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.7.2. Product Portfolio
10.3.7.3. Strategic Overview
10.3.7.4. SWOT Analysis
10.3.8. ColorGenomics
10.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.8.2. Product Portfolio
10.3.8.3. Strategic Overview
10.3.8.4. SWOT Analysis
10.3.9. Ancestry
10.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.9.2. Product Portfolio
10.3.9.3. Strategic Overview
10.3.9.4. SWOT Analysis
10.3.10. WellnessFX
10.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.10.2. Product Portfolio
10.3.10.3. Strategic Overview
10.3.10.4. SWOT Analysis
10.3.11. LetsGetChecked
10.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.11.2. Product Portfolio
10.3.11.3. Strategic Overview
10.3.11.4. SWOT Analysis
10.3.12. Other Prominent Players
10.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.12.2. Product Portfolio
10.3.12.3. Strategic Overview
10.3.12.4. SWOT Analysis



List of Figures

List of Figures

Figure 1: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 2: North America Direct-to-Consumer Laboratory Testing Market Value Share, by Country, 2020 and 2031

Figure 3: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country, 2021–2031

Figure 4: North America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 5: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 6: North America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 7: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 8: North America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by End-user, 2020 and 2031

Figure 9: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by End-user, 2021–2031

List of Tables

List of Tables

Table 01: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 02: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 03: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 04: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 05: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031